Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03973827 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 4, 2019
Last Update Posted : April 3, 2023
|
Sponsor:
NextCell Pharma Ab
Information provided by (Responsible Party):
NextCell Pharma Ab
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | December 10, 2020 |
| Estimated Study Completion Date : | October 30, 2024 |